false
0001037868
0001037868
2026-11-16
2026-11-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 16, 2026
AMETEK, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 1-12981
| Delaware |
|
14-1682544 |
| (State or other jurisdiction of |
|
(I.R.S. Employer |
| incorporation or organization) |
|
Identification No.) |
| |
|
|
| 1100 Cassatt Road Berwyn PA |
|
19312 |
| (Address of principal executive offices) |
|
(Zip Code) |
(610)
647-2121
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report.)
Securities registered pursuant to Section
12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of exchange on which registered |
| Common Stock, $0.01 Par Value (voting) |
AME |
New
York Stock Exchange (NYSE) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 8.01 Other
Events.
USD Notes
On
November 16, 2026, AMETEK, Inc. (the “Company”) entered into an Underwriting Agreement (the “USD Underwriting Agreement”),
by and among the Company, BofA Securities, Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, PNC Capital Markets LLC and Truist
Securities, Inc. on behalf of themselves and as representatives of the several underwriters named therein (the “USD Underwriters”).
The USD Underwriting Agreement provides for the issuance and sale by the Company, and the purchase by the USD Underwriters, of $500,000,000
aggregate principal amount of the Company’s 5.550% Senior Notes due 2031 (the “USD Notes”).
CAD Notes
On
November 16, 2026, the Company entered into an Underwriting Agreement (the “CAD Underwriting Agreement”), by and among
the Company, Merrill Lynch Canada Inc., J.P. Morgan Securities LLC, Scotia Capital Inc., PNC Capital Markets LLC, Truist Securities,
Inc., Wells Fargo Securities Canada, Ltd., BNP Paribas Securities Corp., NatWest Markets Securities Inc. and U.S. Bancorp Investments, Inc. (the
“CAD Underwriters”). The CAD Underwriting Agreement provides for the issuance and sale by the Company, and the purchase
by the CAD Underwriters, of C$600,000,000 aggregate principal amount of the Company’s 4.500% Senior Notes due 2032 (the
“CAD Notes”).
EUR Notes
On
November 16, 2026, the Company entered into an Underwriting Agreement (the “EUR Underwriting Agreement”), by and among the
Company, Merrill Lynch International, J.P. Morgan Securities plc, Wells Fargo Securities International Limited, BNP PARIBAS, Commerzbank
Aktiengesellschaft, NatWest Markets Plc, PNC Capital Markets LLC, Truist Securities, Inc., U.S. Bancorp Investments, Inc. and Scotiabank
(Ireland) Designated Activity Company (the “EUR Underwriters”). The EUR Underwriting Agreement provides for the issuance and
sale by the Company, and the purchase by the EUR Underwriters, of €750,000,000 aggregate principal amount of the Company’s
4.150% Senior Notes due 2030 (the “EUR 2030 Notes”) and €750,000,000 aggregate principal amount of the Company’s
4.450% Senior Notes due 2034 (the “EUR 2034 Notes” and, together with the EUR 2030 Notes, the “EUR Notes”).
The
USD Notes, CAD Notes and EUR Notes are referred to collectively as the “Notes”. Each offering of Notes is expected to close
on November 20, 2026, subject to the satisfaction of customary closing conditions contained in the USD Underwriting Agreement, CAD Underwriting
Agreement and EUR Underwriting Agreement, respectively.
Each
Underwriting Agreement contains customary representations, warranties, covenants and agreements of the Company, and customary
conditions to closing, indemnification rights and termination provisions. The foregoing description of each Underwriting Agreement
does not purport to be complete and is qualified in its entirety by reference to the full text of the applicable Underwriting
Agreement, which is filed as Exhibits 1.1 through 1.3 hereto.
The representations and
warranties set forth in each of the Underwriting Agreements were made solely for the benefit of the parties to the applicable Underwriting
Agreement and (i) should not be treated as categorical statements of fact, but rather as a means of allocating the risk to one of
the parties if those statements prove to be inaccurate, (ii) may have been qualified in the applicable Underwriting Agreement in
accordance with its terms, (iii) may apply contractual standards of “materiality” that are different from “materiality”
under applicable securities laws and (iv) were made only as of the dates specified in the applicable Underwriting Agreement.
The Notes will be senior
unsecured obligations of the Company. The offer and sale of each series of the Notes have been registered under the Securities Act of
1933, as amended, pursuant to the Company’s shelf registration statement on Form S-3 (Registration Statement No. 333-299964) (the
“Shelf Registration Statement”), filed with the Securities and Exchange Commission on November 10, 2026 and are each described
in an applicable Prospectus Supplement dated November 16, 2026.
If the sales of the Notes are
consummated pursuant to the terms set forth in the applicable Underwriting Agreement, the Company estimates that it will receive net
proceeds, after deducting the underwriting discounts and offering expenses of approximately $494,120,000 from the sale of the USD Notes,
C$592,769,460 from the sale of the CAD Notes and €1,490,286,400 from the sale of the EUR Notes. The Company intends to use the
net proceeds of the offerings to repay all or a portion of the outstanding borrowings under its Amended and Restated Credit Agreement
(the “Revolving Credit Agreement”), Term Loan Credit Agreement (the “Term Loan Agreement”, and together with
the Revolving Credit Agreement, the “Financing Agreements”) and/or the Company’s outstanding commercial paper obligations,
and for general corporate purposes.
Certain
of the underwriters and their affiliates have, from time to time, performed, and may in the future perform, various financial advisory,
commercial banking and investment banking services for the Company and its affiliates for which they received, or will receive, customary
fees and expenses. Certain of the underwriters (or affiliates thereof) are acting as joint lead arrangers, joint bookrunners, syndication
agents, administrative agents, adjustment agents, dealers, co-managers or lenders under the Company’s credit facilities, including
the Financing Agreements. In addition, certain affiliates of the underwriters are providing committed financing under the Financing Agreements
and/or the Company’s commercial paper.
Forward-Looking
Statements
Certain
of the statements contained in this Current Report on Form 8-K are “forward-looking statements” within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the
“Securities Exchange Act”). Words such as “aim,” “anticipate,” “believe,”
“can,” “continue,” “could,” “estimate,” “expect,” “intend,”
“may,” “might,” “on track,” “opportunity,” “plan,”
“possible,” “potential,” “predict,” “project,” “seek,”
“should,” “strive,” “sustain,” “synergy,” “target,” “will,”
“would” and similar expressions are intended to identify forward-looking statements, but the absence of these words does
not mean that a statement is not forward-looking. These statements are based on management’s current expectations and are
subject to uncertainty and changes in circumstances and speak only as of the date hereof. These statements are not guarantees of
future performance and are based on assumptions and estimates that could prove incorrect or could cause actual results to vary
materially from those indicated. A more detailed discussion of the risks and uncertainties that could cause the Company’s
actual results to differ materially from those indicated is included in the “Risk Factors” and “Management’s
Discussion and Analysis” sections in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31,
2025 and elsewhere in that report and other reports filed by the Company pursuant to the Securities Exchange Act. The Company
undertakes no obligation to publicly update or revise any forward-looking statements, except as required by the federal securities
laws.
Item 9.01 Financial
Statements and Exhibits.
Exhibit Number |
|
Description |
| |
|
| 1.1 |
|
Underwriting Agreement for the USD Notes, dated as of November 16, 2026, by and among AMETEK, Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, PNC Capital Markets LLC and Truist Securities, Inc., as representatives of the underwriters listed in Schedule 1 thereto. |
| 1.2 |
|
Underwriting Agreement for the CAD Notes, dated as of November 16, 2026, by and among AMETEK, Inc., Merrill Lynch Canada Inc., J.P. Morgan Securities LLC, Scotia Capital Inc., PNC Capital Markets LLC, Truist Securities, Inc., Wells Fargo Securities Canada, Ltd., BNP Paribas Securities Corp., NatWest Markets Securities Inc. and U.S. Bancorp Investments, Inc. |
| 1.3 |
|
Underwriting Agreement for the EUR Notes, dated as of November 16, 2026, by and among AMETEK, Inc., Merrill Lynch International, J.P. Morgan Securities plc, Wells Fargo Securities International Limited, BNP PARIBAS, Commerzbank Aktiengesellschaft, NatWest Markets Plc, PNC Capital Markets LLC, Truist Securities, Inc., U.S. Bancorp Investments, Inc. and Scotiabank (Ireland) Designated Activity Company. |
| 104 |
|
Cover Page Interactive Data File (formatted as inline XBRL) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AMETEK, Inc. |
| |
|
|
| November 18, 2026 |
By: |
/s/ ROBERT J. AMODEI |
| |
|
Name: Robert J. Amodei |
| |
|
Title: Senior Vice President – Controller |